Published in Pathol Biol (Paris) on August 02, 2005
Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol (2006) 1.41
Resemblance and divergence: the "new" members of the genus Bordetella. Med Microbiol Immunol (2010) 1.06
Bordetella petrii infection with long-lasting persistence in human. Emerg Infect Dis (2011) 1.05
Adaptability and persistence of the emerging pathogen Bordetella petrii. PLoS One (2013) 0.97
Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat. Zoonoses Public Health (2012) 0.86
Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres. Eur J Clin Microbiol Infect Dis (2013) 0.85
Septic arthritis and osteomyelitis due to Bordetella petrii. J Clin Microbiol (2014) 0.84
Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis. BMC Microbiol (2013) 0.83
Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect Immun (2014) 0.82
Carbohydrate Structure Database: tools for statistical analysis of bacterial, plant and fungal glycomes. Database (Oxford) (2015) 0.76
Drug Target Identification and Elucidation of Natural Inhibitors for Bordetella petrii: An In Silico Study. Genomics Inform (2016) 0.75
Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol (2000) 18.21
The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun (1999) 6.41
Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother (2004) 3.87
Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science (1997) 3.67
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother (2001) 3.07
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis (1988) 2.71
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology (2001) 2.65
DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother (2005) 2.59
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57
Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol (1993) 2.51
A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett (1997) 2.40
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother (1991) 2.31
Escherichia coli native valve endocarditis. Clin Microbiol Infect (2006) 2.28
Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect Immun (2000) 2.19
Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res Microbiol (1996) 2.11
Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol (1998) 2.10
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (1994) 1.94
Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J (1996) 1.93
Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis (1991) 1.91
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol (1998) 1.83
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett (2001) 1.82
A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 1.77
Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother (2000) 1.63
Clonal dissemination of a CTX-M-15 beta-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother (2006) 1.58
In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy. J Antimicrob Chemother (2001) 1.57
Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med (1997) 1.57
Negative catheter-tip culture and diagnosis of catheter-related bacteremia. Nutrition (1995) 1.52
Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital. J Clin Microbiol (1997) 1.42
Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob Agents Chemother (2001) 1.38
Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France. J Infect Dis (1996) 1.35
Cloning and sequencing of the gene encoding the AmpC beta-lactamase of Morganella morganii. FEMS Microbiol Lett (1997) 1.33
Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiol Infect (1991) 1.33
Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother (2001) 1.32
Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011. Euro Surveill (2011) 1.31
Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin. Antimicrob Agents Chemother (1999) 1.29
[Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 997-2000)]. Pathol Biol (Paris) (2002) 1.26
Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis (1998) 1.25
Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob Agents Chemother (2004) 1.25
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology (1992) 1.24
Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant. Clin Infect Dis (1992) 1.24
In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi. Antimicrob Agents Chemother (1986) 1.20
Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis. Res Microbiol (1994) 1.20
In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones. Antimicrob Agents Chemother (1987) 1.19
Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant (2007) 1.18
The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli. FEMS Microbiol Lett (2001) 1.16
Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. J Clin Microbiol (1998) 1.16
Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis (1997) 1.15
Possible person-to-person transmission of Escherichia coli O111--associated hemolytic uremic syndrome. Pediatr Nephrol (1997) 1.14
CDC group IV c-2: a new Ralstonia species close to Ralstonia eutropha. J Clin Microbiol (1999) 1.13
Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect (2007) 1.13
Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1996) 1.11
Comparative DNA analysis of Bordetella pertussis clinical isolates by pulsed-field gel electrophoresis, randomly amplified polymorphism DNA, and ERIC polymerase chain reaction. FEMS Microbiol Lett (1996) 1.11
Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob Agents Chemother (2001) 1.09
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France. J Infect Dis (2000) 1.08
A beta-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxydans isolated from a case of meningitis. J Antimicrob Chemother (1992) 1.08
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol (2001) 1.08
Genetic environment of acquired bla(ACC-1) beta-lactamase gene in Enterobacteriaceae isolates. Antimicrob Agents Chemother (2006) 1.08
Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid antigen detection test for group A streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis (2013) 1.07
Escherichia hermannii: susceptibility pattern to beta-lactams and production of beta-lactamase. J Antimicrob Chemother (1995) 1.06
Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother (2001) 1.05
Genetic context of plasmid-carried blaCMY-2-like genes in Enterobacteriaceae. Antimicrob Agents Chemother (2009) 1.05
Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia. J Clin Microbiol (2001) 1.04
Automated ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains. J Clin Microbiol (2001) 1.04
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol (2011) 1.02
Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains. Clin Infect Dis (1999) 1.02
A new micromethod for rapid detection of pathogenic bacteria in stool specimens. Eur J Clin Microbiol (1984) 1.01
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill (2010) 1.01
Identification of a carbenicillin-hydrolyzing beta-lactamase in Alcaligenes denitrificans subsp. xylosoxydans. Antimicrob Agents Chemother (1995) 1.01
Diagnosis of venous access port-related infections. Clin Infect Dis (1999) 1.01
[Sensitivity of Pseudomonas aeruginosa and Klebsiella spp. to ceftazidime. Current status in France]. Presse Med (1988) 1.00
Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J (1997) 0.99
Isolation of Kingella kingae in the oropharynx during K. kingae arthritis in children. Clin Microbiol Infect (2012) 0.98
Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med (1991) 0.96
Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis (1998) 0.95
Clonal relationship between U.S. and French serotype V group B streptococcus isolates. J Clin Microbiol (2001) 0.94
Venous access port--related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis (2001) 0.94
[Beta-lactamases of Gram negative bacteria: never-ending clockwork!]. Ann Biol Clin (Paris) (2006) 0.93
[Water origin of Aeromonas hydrophila hospital infections]. Presse Med (1983) 0.93
Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol Biol (Paris) (2008) 0.92
Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J (2001) 0.92
Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect (2009) 0.92
Cellulitis due to Myroides odoratimimus in a patient with alcoholic cirrhosis. Clin Exp Dermatol (2007) 0.91
Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J Hosp Infect (1996) 0.91
Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol (Paris) (2008) 0.91
Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect (2009) 0.90
Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities. Clin Microbiol Infect (2007) 0.90
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (1999) 0.90
Bilateral tibial chronic osteomyelitis due to Pantoea agglomerans in a patient with sickle cell disease. Rheumatology (Oxford) (2007) 0.89
Bacterial contamination of enteral nutrition in a paediatric hospital. J Hosp Infect (2005) 0.89
Association between mortality of Escherichia coli meningitis in young infants and non-virulent clonal groups of strains. Clin Microbiol Infect (2008) 0.89
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli. Antimicrob Agents Chemother (2007) 0.89